USPTO Deadlines
Next Deadline
1017 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20221004)
Due Date
October 04, 2028
Grace Period Ends
April 04, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 4, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Nov 14, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Nov 14, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Nov 3, 2022 | GPAR | P | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | Loading... |
| Oct 4, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 19, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jul 19, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 29, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jun 29, 2022 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Jun 29, 2022 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jun 14, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 9, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 12, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 4, 2021 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Oct 28, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for treating neovascular age-related macular degeneration; pharmaceutical preparations for treating diabetic macular edema; pharmaceutical preparations for the treatment of angiogenesis diseases and disorders; eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; ocular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating diabetes; human vaccine preparations; preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for the treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of inflammatory diseases; antidiabetic preparations; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical preparations for the prevention of ocular disorders or diseases; cardiovascular agents for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; dietary supplements
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005